We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Pacific Biosciences
PACB
$370M
| $730K | ﹤0.01% |
211,482
+17,121
| +9% | +$58.3K |
|
2177
Fossil Group
FOSL
$318M
| $727K | ﹤0.01% |
156,349
-15,245
| -9% | -$58.5K |
|
|
HT
2178
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $725K | ﹤0.01% |
125,790
-11,140
| -8% | -$59.4K |
|
|
TEN
2179
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $725K | ﹤0.01% |
95,888
+2,705
| +3% | +$15.8K |
|
2180
Tucows
TCX
$175M
| $721K | ﹤0.01% |
12,575
+130
| +1% | +$7.22K |
|
|
CODX
2181
Co-Diagnostics
CODX
$5.6M
| $720K | ﹤0.01% |
+1,240
| New | +$566K |
|
|
FBMS
2182
DELISTED
The First Bancshares, Inc.
FBMS
| $718K | ﹤0.01% |
31,928
+6,717
| +27% | +$136K |
|
2183
CEL-SCI Corp
CVM
$30.1M
| $717K | ﹤0.01% |
1,601
+360
| +29% | +$148K |
|
|
NVEE
2184
DELISTED
NV5 Global
NVEE
| $715K | ﹤0.01% |
56,232
+2,500
| +5% | +$28.1K |
|
2185
Prothena Corp
PRTA
$450M
| $715K | ﹤0.01% |
68,351
-10,467
| -13% | -$116K |
|
|
IVC
2186
DELISTED
Invacare Corporation
IVC
| $714K | ﹤0.01% |
112,082
-9,067
| -7% | -$60.7K |
|
2187
Cars.com
CARS
$660M
| $713K | ﹤0.01% |
123,710
+5,173
| +4% | +$28.6K |
|
|
RUTH
2188
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $712K | ﹤0.01% |
87,205
-1,264
| -1% | -$11K |
|
|
BNFT
2189
DELISTED
Benefitfocus, Inc.
BNFT
| $709K | ﹤0.01% |
65,892
-27,673
| -30% | -$303K |
|
|
CPE
2190
DELISTED
Callon Petroleum Company
CPE
| $703K | ﹤0.01% |
61,118
-92,718
| -60% | -$820K |
|
2191
Manitowoc
MTW
$675M
| $700K | ﹤0.01% |
64,299
-1,863
| -3% | -$17.6K |
|
|
VSLR
2192
DELISTED
VIVINT SOLAR, INC.
VSLR
| $697K | ﹤0.01% |
70,453
+14,401
| +26% | +$104K |
|
2193
Conduent
CNDT
$264M
| $696K | ﹤0.01% |
291,293
-10,471
| -3% | -$24.3K |
|
2194
Live Oak Bancshares
LOB
$1.97B
| $694K | ﹤0.01% |
47,831
+5,706
| +14% | +$77.4K |
|
2195
Regis Corp
RGS
$70.2M
| $694K | ﹤0.01% |
4,241
-443
| -9% | -$83.1K |
|
|
HONE
2196
DELISTED
HarborOne Bancorp
HONE
| $693K | ﹤0.01% |
81,123
+34,970
| +76% | +$280K |
|
2197
Mercantile Bank Corp
MBWM
$1.05B
| $692K | ﹤0.01% |
30,609
-400
| -1% | -$8.81K |
|
|
TECX
2198
Tectonic Therapeutic
TECX
$606M
| $691K | ﹤0.01% |
3,298
+1,254
| +61% | +$258K |
|
|
VRTV
2199
DELISTED
VERITIV CORPORATION
VRTV
| $691K | ﹤0.01% |
40,748
-5,554
| -12% | -$65.4K |
|
|
APTS
2200
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $690K | ﹤0.01% |
90,846
+641
| +0.7% | +$4.65K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.